Accuracy of screening tools in diagnosing PAD in diabetes v3.0

  • Research type

    Research Study

  • Full title

    Diagnostic accuracy of ankle brachial pressure index, absolute toe pressures, toe-brachial pressure index, transcutaneous oxygen tension and Doppler waveforms in diagnosing peripheral arterial disease confirmed by gold standard duplex ultrasound imaging, in patients with and without diabetes-related foot ulceration.

  • IRAS ID

    252538

  • Contact name

    Ben Freedman

  • Contact email

    ben.freedman@nhs.net

  • Sponsor organisation

    King’s College Hospital NHS Foundation Trust

  • Duration of Study in the UK

    0 years, 2 months, 2 days

  • Research summary

    Diabetes is a condition that causes people to have too much glucose (sugar) in their blood. High levels of glucose over a long period of time can result in serious damage to different organs, including the heart and blood vessels.

    Damage to the blood vessels can result in a condition known as peripheral arterial disease (PAD). PAD can reduce or obstruct blood supply to parts of the body such as the arms or legs. Reduced blood supply can increase the chance of developing foot problems, such as a foot wound that won’t heal. If foot problems are left untreated they can lead to amputation and increased risk of death. Prevention and appropriate treatment is therefore imperative.

    People with diabetes have an annual foot check to look for any foot problems. During the foot check a trained healthcare professional will look for signs of PAD. Current methods of checking for PAD however are not found to reliable. We therefore aim to look at a range of screening tests to find the best one at detecting PAD.

    To do this, new patients attending the Diabetic Foot Clinic at King’s College Hospital will be invited to participate in the study. If they consent to participate, a range of short screening tests will be carried out during their appointment. Participants will then go on to have an ultrasound scan of both legs. This ultrasound scan will determine whether the participant has PAD.

    The results will therefore indicate which screening test most accurately indicated the presence of PAD. This screening test could then be used in future foot checks to help reliably detect PAD. This will ensure people with diabetes receive appropriate treatment, reducing the chance of serious complications.

  • REC name

    East of England - Cambridge Central Research Ethics Committee

  • REC reference

    19/EE/0034

  • Date of REC Opinion

    28 Jan 2019

  • REC opinion

    Favourable Opinion